Pfizer’s Global Covid-19 Vaccine Rollout Depends on Two Expert Staffers

United States News News

Pfizer’s Global Covid-19 Vaccine Rollout Depends on Two Expert Staffers
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 63%

As countries hunt for more Covid-19 vaccines, companies like Pfizer call on a handful of staffers with the know-how to transfer the technology to contractors

hinges on two employees working on opposite sides of the world.

From her home in Andover, Mass., Amy Genest scouts for companies that can make Pfizer’s shot. After finding a partner, she hands over the project to Poonam Mulherkar, an engineer in Gandhinagar, India, who manages the top-secret transfer of the vaccine’s blueprint and manufacturing.to helping countries overcome limited supplies of dosesVaccine makers like Pfizer, though they have significantly increased their output of shots, can only make so much at their own plants. Mses.

Their work, requiring expertise in biochemical engineering to pharmaceutical manufacturing, is called technology transfer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.Welcome! You are invited to join a meeting: Conversaciones Comunitarias de COVID-19 y la Vacuna de COVID-19 | Community Conversations about COVID-19 and the COVID-19 Vaccine. After registering, you will receive a confirmation email about joining the meeting.
Read more »

As Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in SalesAs Covid-19 Boosters Loom, Pfizer and Moderna Expected to See Billions More in SalesVaccine makers Pfizer and Moderna are on track to notch billions more in sales than previously expected, as new booster-shot strategies and concerns about the Delta variant push demand, and the companies raise prices in the U.S. and elsewhere
Read more »

Covid-19 Booster Shot to Be Offered to Americans Fully Vaccinated With Pfizer, ModernaCovid-19 Booster Shot to Be Offered to Americans Fully Vaccinated With Pfizer, ModernaBreaking: The U.S. will offer a third Covid-19 shot starting in the fall for Americans fully vaccinated with Pfizer or Moderna, to be administered about eight months after the second dose
Read more »

Biden's Recommendation for a Covid-19 Vaccine Booster Shot, ExplainedBiden's Recommendation for a Covid-19 Vaccine Booster Shot, ExplainedYesterday, the White House announced it would recommend people get a booster shot of the Covid-19 vaccine eight months after their second shot. So how did they reach that conclusion?
Read more »

Donald Trump pushes COVID-19 vaccine, says he is 'very proud' of itDonald Trump pushes COVID-19 vaccine, says he is 'very proud' of it'I do believe people have to have their freedoms and all that but, you know, I'd love to see them take the vaccine,' Trump said on Wednesday.
Read more »

COVID-19 live updates: mRNA vaccine efficacy dropped 'significantly' in nursing homesCOVID-19 live updates: mRNA vaccine efficacy dropped 'significantly' in nursing homesThe United States is facing a COVID-19 surge this summer as the more contagious delta variant spreads.
Read more »



Render Time: 2025-02-26 19:10:36